Based on our previous finding, to further characterize the immune status, T cell proliferative history was analyzed in CD4+ and CD8+ T cells from chronic myeloid leukemia (CML) patients. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.